The COVID-19 pandemic brought an enormous urgency to the life sciences sector. Companies vied for suitable treatments and in less than a year, COVID-19 vaccines were developed. This demonstrated clearly that the sector could move at speed when necessary. Though vaccines were supported by regulators, inefficiencies in vaccine and drug development were exposed.
We made bold predictions a year ago about what 2021 would bring. We’re bold enough to do it again for 2022. The pandemic disrupted traditional ways of life in 2021. Remote learning and working became the norm for many. Telehealth took off, and IT modernization accelerated in every industry. 2021
This virus is very scary and it changes constantly. So when you let a virus like that infect millions and millions of people, it's going to make all of those mistakes in copying itself over and over again. - Meghan Schaeffer, Epidemiologist, SAS Meghan Schaeffer, EdD, MPH, MPA, is a
The management of the COVID-19 vaccination program is one of the most complex tasks in modern history. Even without the added complications of administering the vaccine during a pandemic, the race to vaccinate the populations who need it most all while maintaining the necessary cold-storage protocols, meeting double dose requirements,
Cases of the measles have certainly been making headlines in the news recently. And with all the data at our disposal these days, it seems like we should be able to predict which areas in the US are most likely to have measles outbreaks, eh? A group of independent researchers
I recently read an article that said a school in Asheville, North Carolina had the worst chickenpox outbreak in the state in 2 decades. The article was interesting, and it also let me know I had a hole in my knowledge ... "What?!? - There's a chickenpox vaccine?!?" When I
The Wall Street Journal recently published some graphs about seven infectious diseases, and I tried using SAS to improve the graphs ... it's a veritable infectious disease (graph) bake-off! Let's start with Measles ... here's a screen-capture of WSJ's measles graph: In general, their graph is eye-catching, and I learned a lot